Table 3 Correlations between AST/ALT with Cr/CysC*100 and mortality
Variable | 1 year mortality | 2 years mortality | 3 years mortality | |||
|---|---|---|---|---|---|---|
P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | |
AST/ALT | ||||||
Model 1 | ||||||
High muscle mass | – | 1 | – | 1 | – | 1 |
Low muscle mass | 0.001 | 1.52(1.19–1.93) | 0.001 | 1.46(1.16–1.85) | 0.003 | 1.42(1.13–1.79) |
AST/ALT | ||||||
Model 2 | ||||||
High muscle mass | – | 1 | – | 1 | – | 1 |
Low muscle mass | 0.03 | 1.46(1.13–1.88) | 0.008 | 1.39(1.09–1.77) | 0.04 | 1.35(1.06–1.72) |
Cr/ CysC*100 | ||||||
Model 1 | ||||||
High muscle mass | – | 1 | – | 1 | – | 1 |
Low muscle mass | < 0.001 | 2.05(1.6–2.64) | < 0.001 | 2(1.56–2.54) | < 0.001 | 1.98(1.57–2.51) |
Cr/ CysC*100 | ||||||
Model 2 | ||||||
High muscle mass | – | 1 | – | 1 | – | 1 |
Low muscle mass | < 0.001 | 1.9(1.46–2.48) | < 0.001 | 1.85(1.44–2.39) | < 0.001 | 1.85(1.44–2.37) |